Literature DB >> 19435858

Hypocaloric high-protein diet improves fatty liver and hypertriglyceridemia in sucrose-fed obese rats via two pathways.

Takashi Uebanso1, Yutaka Taketani, Makiko Fukaya, Kazusa Sato, Yuichiro Takei, Tadatoshi Sato, Naoki Sawada, Kikuko Amo, Nagakatsu Harada, Hidekazu Arai, Hironori Yamamoto, Eiji Takeda.   

Abstract

The mechanism by which replacement of some dietary carbohydrates with protein during weight loss favors lipid metabolism remains obscure. In this study, we investigated the effect of an energy-restricted, high-protein/low-carbohydrate diet on lipid metabolism in obese rats. High-sucrose-induced obese rats were assigned randomly to one of two energy-restricted dietary interventions: a carbohydrate-based control diet (CD) or a high-protein diet (HPD). Lean rats of the same age were assigned as normal control. There was significantly greater improvement in fatty liver and hypertriglyceridemia with the HPD diet relative to the CD diet. Expression of genes regulated by fibroblast growth factor-21 (FGF21) and involved in liver lipolysis and lipid utilitization, such as lipase and acyl-CoA oxidase, increased in obese rats fed the HPD. Furthermore, there was an inverse correlation between levels of FGF21 gene expression (regulated by glucagon/insulin balance) and increased triglyceride concentrations in liver from obese rats. Expression of hepatic stearoyl-CoA desaturase-1 (SCD1), regulated primarily by the dietary carbohydrate, was also markedly reduced in the HPD group (similar to plasma triglyceride levels in fasting animals) relative to the CD group. In conclusion, a hypocaloric high-protein diet improves fatty liver and hypertriglyceridemia effectively relative to a carbohydrate diet. The two cellular pathways at work behind these benefits include stimulation of hepatic lipolysis and lipid utilization mediated by FGF21 and reduction of hepatic VLDL-TG production by SCD1 regulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19435858     DOI: 10.1152/ajpendo.00014.2009

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  21 in total

1.  Loss of FGF21 in diabetic mouse during hepatocellular carcinogenetic transformation.

Authors:  Quan Zhang; Yan Li; Tingting Liang; Xuemian Lu; Xingkai Liu; Chi Zhang; Xin Jiang; Robert C Martin; Mingliang Cheng; Lu Cai
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

Review 2.  Role of the diet as a link between oxidative stress and liver diseases.

Authors:  Teresa Arrigo; Salvatore Leonardi; Caterina Cuppari; Sara Manti; Angela Lanzafame; Gabriella D'Angelo; Eloisa Gitto; Lucia Marseglia; Carmelo Salpietro
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

3.  Consuming a hypocaloric high fat low carbohydrate diet for 12 weeks lowers C-reactive protein, and raises serum adiponectin and high density lipoprotein-cholesterol in obese subjects.

Authors:  Megan R Ruth; Ava M Port; Mitali Shah; Ashley C Bourland; Nawfal W Istfan; Kerrie P Nelson; Noyan Gokce; Caroline M Apovian
Journal:  Metabolism       Date:  2013-09-26       Impact factor: 8.694

4.  Glucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPARalpha and FGF21 transcripts in vivo.

Authors:  Eric D Berglund; Li Kang; Robert S Lee-Young; Clinton M Hasenour; Daniel G Lustig; Sara E Lynes; E Patrick Donahue; Larry L Swift; Maureen J Charron; David H Wasserman
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-07-27       Impact factor: 4.310

5.  Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?

Authors:  A M Arafat; P Kaczmarek; M Skrzypski; E Pruszyńska-Oszmalek; P Kołodziejski; D Szczepankiewicz; M Sassek; T Wojciechowicz; B Wiedenmann; A F H Pfeiffer; K W Nowak; M Z Strowski
Journal:  Diabetologia       Date:  2012-12-22       Impact factor: 10.122

6.  Paradoxical regulation of human FGF21 by both fasting and feeding signals: is FGF21 a nutritional adaptation factor?

Authors:  Takashi Uebanso; Yutaka Taketani; Hironori Yamamoto; Kikuko Amo; Hirokazu Ominami; Hidekazu Arai; Yuichiro Takei; Masashi Masuda; Ayako Tanimura; Nagakatsu Harada; Hisami Yamanaka-Okumura; Eiji Takeda
Journal:  PLoS One       Date:  2011-08-01       Impact factor: 3.240

7.  Effects of xylitol on metabolic parameters and visceral fat accumulation.

Authors:  Kikuko Amo; Hidekazu Arai; Takashi Uebanso; Makiko Fukaya; Megumi Koganei; Hajime Sasaki; Hironori Yamamoto; Yutaka Taketani; Eiji Takeda
Journal:  J Clin Biochem Nutr       Date:  2011-06-17       Impact factor: 3.114

8.  Hepatic glucagon action is essential for exercise-induced reversal of mouse fatty liver.

Authors:  Eric D Berglund; Daniel G Lustig; Richard A Baheza; Clinton M Hasenour; Robert S Lee-Young; E Patrick Donahue; Sara E Lynes; Larry L Swift; Maureen J Charron; Bruce M Damon; David H Wasserman
Journal:  Diabetes       Date:  2011-09-01       Impact factor: 9.461

9.  Dietary protein affects gene expression and prevents lipid accumulation in the liver in mice.

Authors:  Jessica Schwarz; Daniel Tomé; Annemarie Baars; Guido J E J Hooiveld; Michael Müller
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

10.  Dietary Quality Indices and Biochemical Parameters Among Patients With Non Alcoholic Fatty Liver Disease (NAFLD).

Authors:  Ali Hashemi Kani; Seyed Moayed Alavian; Ahmad Esmaillzadeh; Peyman Adibi; Leila Azadbakht
Journal:  Hepat Mon       Date:  2013-07-13       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.